Phase 2 Endometrial Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have anal, rectal, cervical, vaginal, or vulvar cancer and are receiving radiation treatment aimed at curing the cancer (either radiation alone, or radiation combined with internal radiation called brachytherapy)
- People who are receiving or have previously received chemotherapy alongside their cancer treatment
- People who have had previous surgery on the female reproductive organs
- People who have had rectal surgery (including certain bowel-related operations)
- People who are menopausal, meaning either they are over 50 and have not had a period for 12 months, or they have had both ovaries removed
Who may not be able to join:
- People who have scleroderma, mixed connective tissue disorder, or lupus (certain immune system or connective tissue conditions)
- People who have previously received radiation treatment to the pelvic area
- People who have unexplained abnormal genital bleeding that is not related to their current cancer or its treatment
- People who have cancer or abnormal thickening of the uterine lining (endometrial cancer or endometrial hyperplasia)
- People who have used certain hormone therapies recently — specifically, injectable estrogen-only or progestin implant therapies within the past 3 months before joining the study
- People who have used estrogen pellets or injectable progestin within the past 6 months before joining the study
- People who have used estrogen, progestin, or DHEA taken by mouth, or a hormone-releasing intrauterine device, within the past 8 weeks before joining the study
- People who have used vaginal estrogen products (rings, creams, tablets, or gels), estrogen skin patches, vaginal hyaluronic acid, or herbal treatments that act like estrogen (such as black cohosh) within the past 4 weeks before joining the study
- People with a history of breast cancer
- People who are receiving radiation treatment for palliative (comfort-focused) care rather than curative treatment
- People who do not meet the criteria for menopause as defined by the trial
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Allison M Quick, MD, Ohio State University Comprehensive Cancer Center
Phone: 800-293-5066
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Incidence of grade 2 or higher adverse events
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.